Latest News & Features
Europe
European Commission says pharma firm blocked generics over blockbuster MS drug| Teva “engaged in abusive conduct” to “artificially prolong the exclusivity” of Copaxone | Teva could be found to have infringed Article 102 of TFEU. 11 October 2022
Big Pharma
The partnership aims to progress drug discovery and development | Tech platform accelerates trials and provides higher quality trial data. 11 October 2022
Americas
Dispute against LabCorp claims wilful infringement | Plaintiff has also sued Illumina, Roche and Myriad in separate cases. 6 October 2022
Americas
HEC claims the delay would buy Novartis months of “unjustified monopoly profits” | Response says the Swiss big pharma company makes $3.8m a day from multiple sclerosis drug at issue. 6 October 2022
article
Antiviral treatment could potentially be distributed across 117 countries | MPP looks for interest from potential sublicensees 4 October 2022
article
Bristows has announced that competition law expert Stephen Smith will be the new joint managing partner of the firm 4 October 2022
Big Pharma
Court opens door for US solicitor general to file a brief | Hard fought ‘skinny label’ case centres on a generic medicine maker excluding patent-protected indications from its labels. 4 October 2022
Big Pharma
MSD, known as Merck in the US and Canada, has won against a case concerning branded diabetes treatment Janumet XR at the US Court of Appeals for the Federal Circuit. 29 September 2022
Biotechnology
New partner specialises in chemical-related tech | USPTO-registered litigator is also certified licensing professional | Appointment follows several hires in firm’s patents department. 29 September 2022
Big Pharma
Bid to stay invalidity decision pending a SCOTUS appeal fails | Patent covers a multiple sclerosis drug | Company could take $300m hit if generics are launched. 29 September 2022